Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 290 of 1,261

  1. US 11214803

    Modulators of YAP1 expression

    Ionis Pharmaceuticals, Inc. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  2. US 11214802

    RNAi agents for inhibiting expression of alpha-ENaC and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  3. US 11214801

    RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

    Arrowhead Pharmaceuticals, Inc. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  4. US 11213497

    Antibiofilm formulations

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  5. US 11214603

    C3D cellular and acellular vaccines for the prevention and treatment of cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  6. US 11213588

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  7. US 11213582

    Protection against recurrent genital herpes by therapeutic immunization with herpes simplex virus type 2 ribonucleotide reductase protein subunits

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  8. US 11214574

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  9. US 11214567

    Small molecule inhibitors of MYC and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  10. US 11213514

    Alpha-1-adrenergic receptor agonist therapy

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  11. US 11214595

    BK channel-modulating peptides and their use

    The Board of Regents of the University of Texas System · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  12. US 11213593

    Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates

    Northwestern University · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  13. US 11213524

    Pharmaceutical compositions for subcutaneous administration of levosimendan

    TENAX THERAPEUTICS, INC. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  14. US 11214621

    Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  15. US 11213526

    Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  16. US 11215617

    Treatment of metastatic prostate cancer

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  17. CN 113874050

    MODIFIED CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA · Granted Dec 31, 2021 · Expires Dec 26, 2041

    granted

  18. US 11207394

    Anti-mutated KRAS T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  19. US 11208655

    Functionally-modified oligonucleotides and subunits thereof

    Sarepta Therapeutics, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  20. US 11207270

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  21. US 11207361

    AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  22. US 11208432

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  23. US 11208405

    Pyrrole derivatives as PLK1 inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  24. US 11207329

    Methods for treating GI syndrome and graft versus host disease

    The Board of Regents of the University of Texas System · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.